231 related articles for article (PubMed ID: 30374973)
21. Matrix metalloproteinases in early diabetic retinopathy and their role in alteration of the blood-retinal barrier.
Giebel SJ; Menicucci G; McGuire PG; Das A
Lab Invest; 2005 May; 85(5):597-607. PubMed ID: 15711567
[TBL] [Abstract][Full Text] [Related]
22. Significance of outer blood-retina barrier breakdown in diabetes and ischemia.
Xu HZ; Le YZ
Invest Ophthalmol Vis Sci; 2011 Apr; 52(5):2160-4. PubMed ID: 21178141
[TBL] [Abstract][Full Text] [Related]
23. Fenofibrate prevents the disruption of the outer blood retinal barrier through downregulation of NF-κB activity.
Garcia-Ramírez M; Hernández C; Palomer X; Vázquez-Carrera M; Simó R
Acta Diabetol; 2016 Feb; 53(1):109-18. PubMed ID: 25936740
[TBL] [Abstract][Full Text] [Related]
24. Progressive Early Breakdown of Retinal Pigment Epithelium Function in Hyperglycemic Rats.
Desjardins DM; Yates PW; Dahrouj M; Liu Y; Crosson CE; Ablonczy Z
Invest Ophthalmol Vis Sci; 2016 May; 57(6):2706-13. PubMed ID: 27191823
[TBL] [Abstract][Full Text] [Related]
25. Nicotine promotes blood retinal barrier damage in a model of human diabetic macular edema.
Maugeri G; D'Amico AG; Rasà DM; La Cognata V; Saccone S; Federico C; Cavallaro S; D'Agata V
Toxicol In Vitro; 2017 Oct; 44():182-189. PubMed ID: 28689815
[TBL] [Abstract][Full Text] [Related]
26. δ Opioid Receptor Agonism Preserves the Retinal Pigmented Epithelial Cell Tight Junctions and Ameliorates the Retinopathy in Experimental Diabetes.
Lopes de Faria JM; Duarte DA; Simó R; García-Ramirez M; Dátilo MN; Pasqualetto FC; Lopes de Faria JB
Invest Ophthalmol Vis Sci; 2019 Sep; 60(12):3842-3853. PubMed ID: 31529081
[TBL] [Abstract][Full Text] [Related]
27. Beneficial effects of fenofibrate in retinal pigment epithelium by the modulation of stress and survival signaling under diabetic conditions.
Miranda S; González-Rodríguez Á; García-Ramírez M; Revuelta-Cervantes J; Hernández C; Simó R; Valverde ÁM
J Cell Physiol; 2012 Jun; 227(6):2352-62. PubMed ID: 21826649
[TBL] [Abstract][Full Text] [Related]
28. Systemic administration of HMG-CoA reductase inhibitor protects the blood-retinal barrier and ameliorates retinal inflammation in type 2 diabetes.
Li J; Wang JJ; Chen D; Mott R; Yu Q; Ma JX; Zhang SX
Exp Eye Res; 2009 Jun; 89(1):71-8. PubMed ID: 19254713
[TBL] [Abstract][Full Text] [Related]
29. Scutellarin alleviates blood-retina-barrier oxidative stress injury initiated by activated microglia cells during the development of diabetic retinopathy.
Mei X; Zhang T; Ouyang H; Lu B; Wang Z; Ji L
Biochem Pharmacol; 2019 Jan; 159():82-95. PubMed ID: 30447218
[TBL] [Abstract][Full Text] [Related]
30. Asymmetric dimethylarginine aggravates blood-retinal barrier breakdown of diabetic retinopathy via inhibition of intercellular communication in retinal pericytes.
Huang CY; Zhou T; Li G; Li MY; Xiong XM; Wu MT; Jiang JL
Amino Acids; 2019 Nov; 51(10-12):1515-1526. PubMed ID: 31576457
[TBL] [Abstract][Full Text] [Related]
31. Angiopoietin-Like Protein 4 (ANGPTL4) Induces Retinal Pigment Epithelial Barrier Breakdown by Activating Signal Transducer and Activator of Transcription 3 (STAT3): Evidence from ARPE-19 Cells Under Hypoxic Condition and Diabetic Rats.
Yang X; Cao J; Du Y; Gong Q; Cheng Y; Su G
Med Sci Monit; 2019 Sep; 25():6742-6754. PubMed ID: 31494661
[TBL] [Abstract][Full Text] [Related]
32. Protective effects of methane-rich saline on diabetic retinopathy via anti-inflammation in a streptozotocin-induced diabetic rat model.
Wu J; Wang R; Ye Z; Sun X; Chen Z; Xia F; Sun Q; Liu L
Biochem Biophys Res Commun; 2015 Oct; 466(2):155-61. PubMed ID: 26363454
[TBL] [Abstract][Full Text] [Related]
33. Ursodeoxycholic acid ameliorates diabetic retinopathy via reducing retinal inflammation and reversing the breakdown of blood-retinal barrier.
Ouyang H; Mei X; Zhang T; Lu B; Ji L
Eur J Pharmacol; 2018 Dec; 840():20-27. PubMed ID: 30268667
[TBL] [Abstract][Full Text] [Related]
34. Eriodictyol prevents early retinal and plasma abnormalities in streptozotocin-induced diabetic rats.
Bucolo C; Leggio GM; Drago F; Salomone S
Biochem Pharmacol; 2012 Jul; 84(1):88-92. PubMed ID: 22484312
[TBL] [Abstract][Full Text] [Related]
35. Ethanol Extract of Chinese Propolis Attenuates Early Diabetic Retinopathy by Protecting the Blood-Retinal Barrier in Streptozotocin-Induced Diabetic Rats.
Shi YZ; Liu YC; Zheng YF; Chen YF; Si JJ; Chen ML; Shou QY; Zheng HQ; Hu FL
J Food Sci; 2019 Feb; 84(2):358-369. PubMed ID: 30672592
[TBL] [Abstract][Full Text] [Related]
36. Nap Interferes with Hypoxia-Inducible Factors and VEGF Expression in Retina of Diabetic Rats.
D'Amico AG; Maugeri G; Bucolo C; Saccone S; Federico C; Cavallaro S; D'Agata V
J Mol Neurosci; 2017 Feb; 61(2):256-266. PubMed ID: 27909871
[TBL] [Abstract][Full Text] [Related]
37. Blood-retinal barrier protection against high glucose damage: The role of P2X7 receptor.
Platania CBM; Lazzara F; Fidilio A; Fresta CG; Conti F; Giurdanella G; Leggio GM; Salomone S; Drago F; Bucolo C
Biochem Pharmacol; 2019 Oct; 168():249-258. PubMed ID: 31302133
[TBL] [Abstract][Full Text] [Related]
38. Natural flavonoid galangin alleviates microglia-trigged blood-retinal barrier dysfunction during the development of diabetic retinopathy.
Zhang T; Mei X; Ouyang H; Lu B; Yu Z; Wang Z; Ji L
J Nutr Biochem; 2019 Mar; 65():1-14. PubMed ID: 30597356
[TBL] [Abstract][Full Text] [Related]
39. Fenofibric acid prevents retinal pigment epithelium disruption induced by interleukin-1β by suppressing AMP-activated protein kinase (AMPK) activation.
Villarroel M; Garcia-Ramírez M; Corraliza L; Hernández C; Simó R
Diabetologia; 2011 Jun; 54(6):1543-53. PubMed ID: 21369818
[TBL] [Abstract][Full Text] [Related]
40. High glucose concentration leads to differential expression of tight junction proteins in human retinal pigment epithelial cells.
Villarroel M; García-Ramírez M; Corraliza L; Hernández C; Simó R
Endocrinol Nutr; 2009 Feb; 56(2):53-8. PubMed ID: 19627712
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]